Vobarilizumab Uses, Dosage, Side Effects and more
Vobarilizumab is under investigation in clinical trial NCT02101073 (ALX-0061 Phase I Bioavailability Study in Healthy Volunteers).
| Attribute | Details |
|---|---|
| Trade Name | Vobarilizumab |
| Generic | Vobarilizumab |
| Vobarilizumab Other Names | Vobarilizumab |
| Type | |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
